Sialyltransferase STX (ST8SiaII): A novel molecular marker of metastatic neuroblastoma

International Journal of Cancer

Volumn 119, Issue 1, 2006, Pages 152-156

  Cheung, Irene Y ^a   Vickers, Andrew ^a   Cheung, Nai Kong V ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Marker validation; Minimal residual disease; Polysialic acid (PSA); Sialyltransferase X

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3F8; POLYSIALIC ACID; SIALYLTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CELL ADHESION; CELL MIGRATION; CHILD; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE MARKER; HIGH RISK PATIENT; HUMAN; HUMAN CELL; IMMUNOTHERAPY; INFANT; MAJOR CLINICAL STUDY; METASTASIS; MONONUCLEAR CELL; NERVE CELL; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

CELL LINE, TUMOR; FEMALE; HUMANS; INFANT; MALE; NEOPLASM, RESIDUAL; NEUROBLASTOMA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SIALYLTRANSFERASES; TUMOR MARKERS, BIOLOGICAL;

EID: 33646511107     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.21789     Document Type: Article

References (21)

1. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 2003;22:2318-23.
2. Storms SD, Rutishauser U. A role for polysialic acid in neural cell adhesion molecule heterophilic binding to proteoglycans. J Biol Chem 1998;273:27124-9.
3. Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, Li M, Yanagihara K, Nakayama J, Fujimoto I, Ikenaka K, Wada H. Expression of polysialic acid and STX, a human polysialyltransferase, is correlated with tumor progression in non-small cell lung cancer. Cancer Res 2000;60:3072-80.
4. Fukuda M. Possible roles of tumor-associated carbohydrate antigens. Cancer Res 1996;56:2237-44.
5. Scheidegger EP, Lackie PM, Papay J, Roth J. In vitro and in vivo growth of clonal sublines of human small cell lung carcinoma is modulated by polysialic acid of the neural cell adhesion molecule. Lab Invest 1994;70:95-106.
6. Tanaka F, Otake Y, Nakagawa T, Kawano Y, Miyahara R, Li M, Yanagihara K, Inui K, Oyanagi H, Yamada T, Nakayama J, Fujimoto I, et al. Prognostic significance of polysialic acid expression in resected non-small cell lung cancer. Cancer Res 2001;61:1666-70.
7. Gluer S, Zense M, Radtke E, von Schweinitz D. Polysialylated neural cell adhesion molecule in childhood ganglioneuroma and neuroblastoma of different histological grade and clinical stage. Langenbecks Arch Surg 1998;383:340-4.
8. Soler AP, Johnson KR, Wheelock MJ, Knudsen KA. Rhabdomyosarcoma-derived cell lines exhibit aberrant expression of the cell-cell adhesion molecules N-CAM, N-cadherin, and cadherin-associated proteins. Exp Cell Res 1993;208:84-93.
9. Roth J, Zuber C, Wagner P, Taatjes DJ, Weisgerber C, Heitz PU, Goridis C, Bitter-Suermann D. Reexpression of poly(sialic acid) units of the neural cell adhesion molecule in Wilms tumor. Proc Natl Acad Sci USA 1988;85:2999-3003.
10. Mayanil CS, George D, Freilich L, Miljan EJ, Mania-Farnell B, McLone DG, Bremer EG. Microarray analysis detects novel Pax3 downstream target genes. J Biol Chem 2001;276:49299-309.
11. Nakayama J, Angata K, Ong E, Katsuyama T, Fukuda M. Polysialic acid, a unique glycan that is developmentally regulated by two polysialyltransferases, PST and STX, in the central nervous system: from biosynthesis to function. Pathol Int 1998;48:665-77.
12. Hildebrandt H, Becker C, Gluer S, Rosner H, Gerardy-Schahn R, Rahmann H. Polysialic acid on the neural cell adhesion molecule correlates with expression of polysialyltransferases and promotes neuroblastoma cell growth. Cancer Res 1998;58:779-84.
13. Kushner BH, Kramer K, Cheung NKV. Phase II trial of the anti-GD2 monoclonal antibody 3F8 and granulocyte-macrophage colony-stimulating factor for neuroblastoma. J Clin Oncol 2001;19:4189-94.
14. Brodeur G, Pritchard J, Berthold F, Carlen NLT, Castel V, Castleberry RP, DeBernardi B, Evans AE, Favrot M, Hedborg F, Kaneko M, Kemshead J, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging and response to treatment. J Clin Oncol 1993;11:1466-77.
15. Cheung NK, Heller G, Kushner BH, Liu C, Cheung IY. Detection of metastatic neuroblastoma in bone marrow: when is routine marrow histology insensitive? J Clin Oncol 1997;15:2807-17.
16. Cheung IY, Cheung NKV. Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma. Clin Cancer Res 1997;3:821-6.
17. Cheung IY, Cheung NK. Quantitation of marrow disease in neuroblastoma by real-time reverse transcription-PCR. Clin Cancer Res 2001;7:1698-705.
18. Walton JD, Kattan DR, Thomas SK, Spengler BA, Biedler JL, Cheung NK, Ross RA. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004;6:838-45.
19. Bilke S, Chen QR, Westerman F, Schwab M, Catchpoole D, Khan J. Inferring a tumor progression model for neuroblastoma from genomic data. J Clin Oncol 2005;23:7322-31.
20. Cheung IY, Vickers A, Gerald W, Cheung N-KV. Exploiting genome-wide expression arrays in cancer marker discovery: validation of cyclin D1 as a sensitive molecular marker of minimal residual disease in neuroblastoma. Proc Am Assoc Cancer Res 2005;45(Suppl):96-7.
21. Zhang S, Cordon-Cardo C, Zhang HS, Reuter VE, Adluri S, Hamilton WB, Lloyd KO, Livingston PO. Selection of tumor antigens as targets for immune attack using immunohistochemistry. I. Focus on gangliosides. Int J Cancer 1997;73:42-9.